Successful Treatment of Post-Transplant Relapsed Acute Myeloid Leukemia With FLT3 Internal Tandem Duplication Using the Combination of Induction Chemotherapy, Donor Lymphocyte Infusion, Sorafenib and Azacitidine. Report of Three Cases

Einstein (São Paulo, Brazil)- Brazil

doi 10.1590/s1679-45082017rc3784

Full Text

Abstract

Available in

Categories

Medicine

Date

Authors

Publisher

FapUNIFESP (SciELO)

Related search

Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

Leukemia Research
Cancer ResearchOncologyHematology
2016English

Improved FLT3 Internal Tandem Duplication PCR Assay Predicts Outcome After Allogeneic Transplant for Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Flt3 Internal Tandem Duplication and P-Glycoprotein Functionality in 171 Patients With Acute Myeloid Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2006English

Sorafenib as Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

JAMA Oncology
Cancer ResearchOncology
2018English

Radius: Midostaurin (Mido) Plus Standard of Care (SOC) After Allogeneic Stem Cell Transplant (alloSCT) in Patients (Pts) With FLT3-Internal Tandem Duplication (ITD)–Mutated Acute Myeloid Leukemia (AML)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

Treatment of Relapsed Acute Myeloid Leukemia With MLL/AF6 Fusion After Allogeneic Hematopoietic Stem Cell Transplantation With Gemtuzumab Ozogamicin With a Long Interval Followed by Donor Lymphocyte Infusion

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy